6640--BioCartis Idylla Assay Kits
Veterans Affairs · 246-NETWORK CONTRACTING OFFICE 6 (36C246)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24625Q0205 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Biocartis Idylla Assay Cartridges
Who won similar work
7 award notices on SAM.gov in the last 24 months. Matched by: Same office (246-NETWORK CONTRACTING OFFICE 6 (36C246)), same product/service code (PSC) 6640.
Single-winner award sizes (7): middle half $208K to $3.3M, median $388K; range $16K to $5.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| WERFEN USA LLC | 2 | $415K | Oct 7, 2026 |
| AMERICAN NATIONAL RED CROSS, THE CHARLOTTE 28273 NCL | 1 | $5.8M | Dec 2, 2024 |
| ROCHE DIAGNOSTICS CORPORATION | 1 | $5.2M | Oct 9, 2025 |
| BRANCH MEDICAL LLC · $GMED · $1.6B | 1 | $1.5M | Jan 22, 2026 |
| BINDING SITE, INC. · $TMO · $42.9B | 1 | $388K | Feb 6, 2025 |
| APEX INTEGRATED DISTRIBUTION INC. | 1 | $16K | Jun 3, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $GMED reported $1.6B revenue in FY2025. The median single-winner award in these 7 past awards, $388K, is under 0.1% of that. 10-K
- $TMO reported $42.9B revenue in FY2025. The median single-winner award in these 7 past awards, $388K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 7, 2026WERFEN USA LLC$346K6640--ECHO LUMENA- WERFEN
- Oct 7, 2026WERFEN USA LLC$69K6640--ECHO LUMENA- WERFEN
- Jan 22, 2026BRANCH MEDICAL LLC$1.5M6640--BioPlex 2200 Supplies
- Oct 9, 2025ROCHE DIAGNOSTICS CORPORATION$5.2M6640--VISN6 HISTOLOGY IDIQ
- Jun 3, 2025APEX INTEGRATED DISTRIBUTION INC.$16K6640--Copy of LAB FREEZZER
- Feb 6, 2025BINDING SITE, INC.$388K6640--Turbidimetric Immunodiagnostic Instrument Rental/Testing
- Dec 2, 2024AMERICAN NATIONAL RED CROSS, THE CHARLOTTE 28273 NCL$5.8M6640--Richmond and Salem Blood and Blood Components
Competitive landscape
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (1 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $40K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 7 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.